Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00169234 · ClinicalTrials.gov registry record · Phase 1

Pneumococcal Adult-dose Ranging Immunization Study

A Phase 1 study of Pneumonia, sponsored by Kaiser Permanente.

Completed
Registry status
Phase 1
Development phase
220
Enrollment target
2
Study locations

NCT00169234 is a Phase 1 study of Pneumonia that has completed, run by Kaiser Permanente. The registered enrollment target is 220 participants, below the 4,515-participant average among 47 other Pneumonia trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00169234, a Phase 1 study of Pneumonia, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
Phase 1
Development phase
220 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to give seniors different doses of a new pneumococcal vaccine called PCV7 to evaluate the safety of the vaccine and compare the immune response to find out which amount gives the best immune response. The PCV7 vaccine is currently licensed by the FDA for use in infants and toddlers only.

Conditions Studied

Pneumonia

Interventions

  • BIOLOGICAL PCV7, Prevnar®
  • BIOLOGICAL Pneumovax 23

Study Locations (2)

Washington

  • Group Health Research Institute - Seattle
  • VA Puget Sound Health Care System - Seattle

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2003-05
Est. Completion 2005-02
Phase Phase 1

Sponsor

Kaiser Permanente

294 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00169234

The ClinicalTrials.gov registry entry for NCT00169234 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,515-participant average among 47 other Pneumonia trials with a reported enrollment target (95% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which PCV7, Prevnar® is the first listed.

NCT00169234 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00169234 about?

NCT00169234 is a clinical study titled "Pneumococcal Adult-dose Ranging Immunization Study". The purpose of this study is to give seniors different doses of a new pneumococcal vaccine called PCV7 to evaluate the safety of the vaccine and compare the immune response to find out which amount gives the best immune response. The PCV7 vaccine is currently licensed by the FDA for use in infants a...

What is the current status of trial NCT00169234?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 220 participants. The study started on 2003-05. Estimated completion is 2005-02.

What conditions does trial NCT00169234 study?

This clinical trial studies the following conditions: Pneumonia.

What interventions are being tested in trial NCT00169234?

The interventions under investigation include: PCV7, Prevnar® (BIOLOGICAL), Pneumovax 23 (BIOLOGICAL).

Who is sponsoring clinical trial NCT00169234?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00169234 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pneumonia

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.